Isabel Preeshagul is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 118 publications with 1,954 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1275 York Ave
New York, NY 100656007
Telephone
212-639-2000Provider last certified this registry record 8 Nov 2024.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202514 payments
- Regeneron Healthcare Solutions, Inc.Program year20252 payments
- AstraZeneca UK LimitedProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
34.3%Serotonin-3 Receptor Antagonist12.6%Ondansetron Hcl100%Part D≥36 patientsCorticosteroid7.4%Prednisone100%Part D≥11 patients+ 3 more classes in this area
Cancer & immunology
24.6%Kinase inhibitor24.6%Tagrisso85%Retevmo15%Part D<11 patientsSensory organs
17.4%Corticosteroid17.4%Dexamethasone100%Part D≥37 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Addressing clinical trial barriers in lung cancer: Patient-reported impact of resources on trial participation.
Journal of Clinical Oncology
2025 - Patient-reported experience with an immunotherapy telehealth platform.
Journal of Clinical Oncology
2025 - Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
Journal of Clinical Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”